[High prevalence of antiviral resistant influenza, and reduced clinical effectiveness of the antivirals against resistant influenza strains].
Saito
Reiko
R
D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001363:Awards and Prizes; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology* / Q000821:virology*; D007564:Japan / Q000453:epidemiology; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D009975:Orthomyxoviridae / Q000145:classification / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D053139:Oseltamivir / Q000494:pharmacology* / Q000627:therapeutic use; D015995:Prevalence; D013997:Time Factors
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase